Fuwai PCI Registry Analysis: Prolonged DAPT Should Remain Standard of Care for High-Risk ACS Post-PCI
Prolonged dual antiplatelet therapy (DAPT) should remain the standard of care for high-risk acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI) despite recent calls to shorten treatment time, according to a new analysis of the prospective Fuwai PCI Registry.